« Return to News | CROs/Service Providers

LabCorp to Acquire Tandem Labs

Monday, January 28, 2008 07:44 AM

Burlington, N.C.-based LabCorp has signed an agreement to acquire the bioanalytical services company Tandem Labs for an undisclosed amount. Tandem performs analytical lab work for drugs in all stages of development including discovery, preclinical, and clinical. Founded in 1981 as Northwest Toxicology Consultants, the company initially operated as a clinical toxicology reference laboratory.

LabCorp is the second largest reference laboratory testing company in the U.S., but its client base is primarily hospitals, clinics and government agencies. It offers tests ranging from routine blood analyses to HIV and genomic testing. Tandem Labs will join the Esoterix clinical trials group at LabCorp and maintain both its name and management.

LabCorp has revenues of $3.5 billion and 23,500 employees. The company has a network of 36 laboratories and 1,300 service sites.

The bulk of LabCorp’s testing business involves performing quick routine tests on more than 360,000 patient specimens daily, serving hospitals, clinics, doctor’s offices, law enforcement agencies and medical testing centers. As with most reference labs, its most frequently requested tests include blood chemistry analyses, urinalyses, blood cell counts, Pap, HIV, and substance-abuse tests.

LabCorp’s central laboratory business generates 2% of its revenue. The company has a 4% share of the central labs market, holding steady since 2003. Its clinical testing headquarters is located in Raritan, N.J., and its European headquarters, in Belgium.

The deal is expected to close in the first quarter of 2008.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.